Ching-Wei Chang

1.2k total citations · 1 hit paper
8 papers, 917 citations indexed

About

Ching-Wei Chang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Ching-Wei Chang has authored 8 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Infectious Diseases. Recurrent topics in Ching-Wei Chang's work include Oral health in cancer treatment (3 papers), Gut microbiota and health (2 papers) and Advanced Breast Cancer Therapies (1 paper). Ching-Wei Chang is often cited by papers focused on Oral health in cancer treatment (3 papers), Gut microbiota and health (2 papers) and Advanced Breast Cancer Therapies (1 paper). Ching-Wei Chang collaborates with scholars based in Taiwan, United States and North Korea. Ching-Wei Chang's co-authors include Tung‐Hu Tsai, Chia-Yuan Liu, Joseph P. Eder, Rita Nanda, Sara M. Tolaney, Cristina Cruz, William Grossman, Leisha A. Emens, Fadi Braiteh and Carol O’Hear and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Microbiology and Journal of Ethnopharmacology.

In The Last Decade

Ching-Wei Chang

8 papers receiving 908 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer

2018 567 citations Leisha A. Emens, Cristina Cruz et al. JAMA Oncology profile →

Peers

Ching-Wei Chang

ONCOL

MB

PRM

IMMUN

CR

Fangfang Duan China

Vida Hashemi Iran

Neşe Ünver Türkiye

Pengbo Deng China

Aimin Jiang China

Ali Adili Iran

Xi Xu China

Dan Pu China

Kamila Wojas‐Krawczyk Poland

Fangfang Duan China

Ching-Wei Chang

182 ×0.3

ONCOL

317 ×1.1

MB

128 ×0.5

PRM

209 ×0.9

IMMUN

164 ×1.3

CR

Citations per year, relative to Ching-Wei Chang Ching-Wei Chang (= 1×) peers Fangfang Duan

Countries citing papers authored by Ching-Wei Chang

Since Specialization

Citations

This map shows the geographic impact of Ching-Wei Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching-Wei Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching-Wei Chang more than expected).

Fields of papers citing papers by Ching-Wei Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching-Wei Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching-Wei Chang. The network helps show where Ching-Wei Chang may publish in the future.

Co-authorship network of co-authors of Ching-Wei Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Ching-Wei Chang. A scholar is included among the top collaborators of Ching-Wei Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching-Wei Chang. Ching-Wei Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Hsieh, Chen-Hsi, et al.. (2021). Anti-inflammatory effects of Radix Aucklandiae herbal preparation ameliorate intestinal mucositis induced by 5-fluorouracil in mice. Journal of Ethnopharmacology. 271. 113912–113912. 30 indexed citations

2.

Chang, Ching-Wei, Hung-Chang Lee, Jen‐Shiu Chiang Chiau, et al.. (2020). Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer. International Journal of Molecular Sciences. 21(2). 386–386. 161 indexed citations

3.

Chang, Ching-Wei, Chia-Yuan Liu, Yen‐Hua Huang, et al.. (2018). Lactobacillus casei Variety rhamnosus Probiotic Preventively Attenuates 5-Fluorouracil/Oxaliplatin-Induced Intestinal Injury in a Syngeneic Colorectal Cancer Model. Frontiers in Microbiology. 9. 983–983. 116 indexed citations

4.

Emens, Leisha A., Cristina Cruz, Joseph P. Eder, et al.. (2018). Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer. JAMA Oncology. 5(1). 74–74. 567 indexed citations breakdown →

5.

Hung, Chung‐Lieh, Szu‐Hua Pan, Chia‐Li Han, et al.. (2017). Membrane Proteomics of Impaired Energetics and Cytoskeletal Disorganization in Elderly Diet-Induced Diabetic Mice. Journal of Proteome Research. 16(10). 3504–3513. 7 indexed citations

6.

Liu, Chia-Yuan, Ching-Wei Chang, Hung-Chang Lee, et al.. (2016). Metabolic Damage Presents Differently in Young and Early-Aged C57BL/6 Mice Fed a High-Fat Diet. International journal of gerontology. 10(2). 105–111. 19 indexed citations

7.

Fang, Jia‐Long, Tao Han, Qiangen Wu, et al.. (2013). Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Archives of Toxicology. 88(3). 609–23. 7 indexed citations

8.

Chang, Ching-Wei, Feng‐Nien Ko, Ming‐Jai Su, Yang‐Chang Wu, & Che‐Ming Teng. (1997). Pharmacological Evaluation of Ocoteine, Isolated from Cassytha filiformis, as an α1Adrenoceptor Antagonist in Rat Thoracic Aorta. The Japanese Journal of Pharmacology. 73(3). 207–214. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact